ORBIMED ADVISORS LLC

Q2 2023 13F-HR Detailed Holdings

Location
New York, NY
Holdings as of
6/30/2023
Date filed
8/14/2023
Form type
13F-HR
Num holdings
127
Total value ($000)
$5,518,910
Net value change ($000)
+424,864 (8.3%)
New positions
16
Sold out positions
12
Turnover %
11.7%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q1 2023
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
ACELYRIN, Inc. 111,320 NEW
BAX 90,410 142.7%
UTHR 88,719 NEW
MDGL 74,282 NEW
ISRG 53,655 33.8%
IRON 52,678 109.5%
CI 45,177 NEW
VectivBio Holding AG 43,780 99.8%
R1 RCM Inc. /DE 37,236 141.9%
ZBH 35,672 NEW
Top Reduces (Value $000, Stocks/ETFs)
BMY -67,027 -41.3%
CHINOOK THERAPEUTICS, INC. -46,978 -100.0%
SRPT -44,341 -37.2%
BELLUS Health Inc. -36,756 -100.0%
PGNY -33,338 -100.0%
AMLX -23,868 -100.0%
TERN -23,544 -26.1%
ACET -22,673 -52.9%
SYK -22,138 -21.1%
XBI -20,882 -100.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 40,384 (0.7% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 ORBIMED CAPITAL LLC 028-10410